Nr. Crt.NumeStatusLocatie
1.A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate CancerIn curs de recrutareCentrul de Oncologie Sf. Nectarie SRL   Craiova, Dolj, Romania, 200347 Contact    40351401336       Principal Investigator: Michael Schenker          S.C. R.T.C. Radiology Therapeutic Center S.R.L.   Otopeni, Ilfov, Romania, 075100 Contact    40372744344       Principal Investigator: Elena Ciubotaru          SC Gral Medical SRL   Bucuresti, Romania, 031422 Contact    40213230000       Principal Investigator: Cristina Tiut          Spitalul Clinic Judetean de UrgentaSf.Apostol Andrei Constanta   Constanta, Romania, 900591 Contact    40241662222       Principal Investigator: Laura Mazilu   
2.A Study of Nivolumab or Placebo in Combination With Docetaxel in Men With Advanced Castration-resistant Prostate CancerIn curs de recrutareLocal Institution Not yet recruiting Craiova, Dolj, Romania, 200347 Contact: Site 0052          Local Institution Not yet recruiting Bucharest, Romania, 022328 Contact: Site 0042          Local Institution Not yet recruiting Cluj Napoca, Romania, 400015 Contact: Site 0041          Local Institution Not yet recruiting Cluj Napoca, Romania, 400015 Contact: Site 0043          Local Institution Not yet recruiting Constanta, Romania, 900591 Contact: Site 0020          Local Institution Not yet recruiting Timisoara, Romania, 300239 Contact: Site 0035         
3.Study of Ipatasertib or Apitolisib With Abiraterone Acetate Versus Abiraterone Acetate in Participants With Castration-Resistant Prostate Cancer Previously Treated With Docetaxel ChemotherapyIn curs de recrutareSf. Constantin Hospital; Oncology Completed Brasov, Romania, 500019 Prof. Dr. Th. Burghele Clin Urology Hosp Active, not recruiting Bucharest, Romania, 050659 Prof. Dr. I. Chiricuta Institute of Oncology Completed Cluj Napoca, Romania, 400015 Institute of Oncology „Prof. Dr. I. Chiricuta” Not yet recruiting Cluj-Napoca, Romania, 400015 ONCOMED – Medical Centre Completed Timisoara, Romania, 300239 Municipal Hosp Turdal; Oncology Completed Turda, Romania, 401103
  4.  A Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)  Activ, inca nu recruteaza  Site RO40008 Cluj-Napoca, Cluj, Romania Site RO40009 Cluj-Napoca, Cluj, Romania Site RO40002 Floresti, Cluj, Romania Site RO40011 Timisoara, Timis, Romania Site RO40007 Brasov, Romania Site RO40003 Bucharest, Romania Site RO40006 Bucharest, Romania
5.An Efficacy and Safety Study of JNJ-56021927 (Apalutamide) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLASActiv, inca nu recruteazaBucuresti, Romania Cluj-Napoca, Romania Floresti, Romania Iasi, Romania Otopeni, Romania Ploiesti, Romania Sibiu, Romania TarguMures, Romania Timisoara, Romania
6.A Study of Apalutamide (ARN-509) in Men With Non-Metastatic Castration-Resistant Prostate CancerActiv, inca nu recruteazaBaia Mare, Romania Brasov, Romania Bucharest, Romania Cluj- Napoca, Romania TarguMures, Romania
7.Efficacy and Safety Study of Darolutamide (ODM-201) in Men With High-risk Nonmetastatic Castration-resistant Prostate CancerActiv, inca nu recruteaza  Bucuresti, Romania, 22328 Bucuresti, Romania, 41345 Bucuresti, Romania, 50659 Bucuresti, Romania, 75000 Cluj-Napoca, Romania, 400015 Craiova, Romania, 200385 Craiova, Romania, 200642 Oradea, Romania, 410159 Ploiesti, Romania, 100337 Targu-Mures, Romania, 540103
8.A Study of Apalutamide (JNJ-56021927, ARN-509) Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants With mHSPCActiv, inca nu recruteazaBucharest, Romania Cluj Napoca, Romania Craiova, Romania TarguMures, Romania
9.A Phase III Study for Patients With Metastatic Hormone-naïve Prostate CancerActiv, inca nu recruteazaSc Radiotherapy Center Cluj SRL Cluj, Romania
10.A Study of Abiraterone Acetate Plus Low-Dose Prednisone Plus Androgen Deprivation Therapy (ADT) Versus ADT Alone in Newly Diagnosed Participants With High-Risk, Metastatic Hormone-Naive Prostate Cancer (mHNPC)Activ, inca nu recruteazaBrasov, Romania Bucharest, Romania Bucuresti, Romania Cluj Napoca, Romania Iasi, Romania
11A Study of Comparative Formulations of Niraparib and Abiraterone Acetate (AA) in Men With Prostate CancerActiv, inca nu recruteazaArensia Exploratory Medicine Bucharest, Romania, 21105
(Visited 38 times, 1 visits today)